← Leaderboards
Julie A Schneider
Rush University Medical Center
$29,310,501
Attributed
$43,728,548
Total exposure
18
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.5M · FY2006–25$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$56,151,133 · 19
By mechanism
P30$18,659,222 · 6
R01$15,998,734 · 5
RF1$8,251,094 · 2
U01$3,480,622 · 1
UH3$3,477,833 · 1
UF1$2,472,997 · 1
Top collaborators
- Konstantinos Arfanakis15 shared
- Ashley I Bush5 shared
- Mathew Mark Blurton-Jones1 shared
- Yadong Huang1 shared
- Andrew Chris Yang1 shared
Most similar at Rush University Medical Center
Same institution · by research overlap
- Martha C. Morris$22,587,904
- Ashley I Bush$3,903,973
- Aron S Buchman$27,290,421
- Victoria Lutgen Gronau$177,226
- Laura Tran$92,788
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAgingS DiseaseNeuropathologyBrainDementiaAutopsyPathologicImpaired CognitionDiagnosisPathologyResourcesCohortPreventionCessation Of LifeMemoryParticipantLinkBiological MarkersCognitiveBlood VesselsCommunitiesElderlyCohort Studies
Grant awards (61)
Rush Alzheimer's Disease Research Center$3,103,082
P30 · FY2025 · AG · contact PI
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia$1,138,042
U01 · FY2025 · NS
Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease$575,769
R01 · FY2025 · AG · contact PI
Core D: Neuropathology Core$384,650
P30 · FY2025 · AG · contact PI
Vanderbilt Alzheimer's Disease Research Center: Neuropathology Core$316,592
P30 · FY2025 · AG · contact PI
Vascular-immune mechanisms of cerebral amyloid angiopathy and Alzheimer's pathology$5,423,836
RF1 · FY2024 · NS
Rush Alzheimer's Disease Research Center$3,104,748
P30 · FY2024 · AG · contact PI
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging$1,364,712
R01 · FY2024 · AG · contact PI
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia$1,158,160
U01 · FY2024 · NS
Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease$597,000
R01 · FY2024 · AG · contact PI
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology$504,727
U19 · FY2024 · AG · contact PI
Core D: Neuropathology Core$384,650
P30 · FY2024 · AG · contact PI
Rush Alzheimer's Disease Research Center$3,106,478
P30 · FY2023 · AG · contact PI
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging$1,364,712
R01 · FY2023 · AG · contact PI
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia$1,184,420
U01 · FY2023 · NS
In-vivo MRI-based prediction of TDP43 pathology in aging$615,344
R01 · FY2023 · AG
Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease$602,400
R01 · FY2023 · AG · contact PI
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology$512,856
U19 · FY2023 · AG · contact PI
Core D: Neuropathology Core$384,650
P30 · FY2023 · AG · contact PI
Rush Alzheimer's Disease Research Center$3,108,277
P30 · FY2022 · AG · contact PI
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging$1,372,405
R01 · FY2022 · AG · contact PI
In-vivo MRI-based prediction of TDP43 pathology in aging$655,533
R01 · FY2022 · AG
Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease$611,019
R01 · FY2022 · AG · contact PI
Core D: Neuropathology Core$384,650
P30 · FY2022 · AG · contact PI
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia$2,472,997
UF1 · FY2021 · NS
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging$1,331,164
R01 · FY2021 · AG · contact PI
In-vivo MRI-based prediction of TDP43 pathology in aging$663,226
R01 · FY2021 · AG
Diet Patterns and Alzheimer Disease and Other Dementias$432,876
R01 · FY2021 · AG · contact PI
Core D: Neuropathology Core$384,650
P30 · FY2021 · AG · contact PI
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging$1,332,577
R01 · FY2020 · AG · contact PI
Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.$1,159,758
UH3 · FY2020 · NS · contact PI
In-vivo MRI-based prediction of TDP43 pathology in aging$655,533
R01 · FY2020 · AG
Core D: Neuropathology Core$422,774
P30 · FY2020 · AG · contact PI
Diet Patterns and Alzheimer Disease and Other Dementias$373,971
R01 · FY2020 · AG · contact PI
Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.$1,152,217
UH3 · FY2019 · NS · contact PI
In-vivo MRI-based prediction of TDP43 pathology in aging$708,822
R01 · FY2019 · AG
Core D: Neuropathology Core$419,138
P30 · FY2019 · AG · contact PI
Diet Patterns and Alzheimer Disease and Other Dementias$373,971
R01 · FY2019 · AG · contact PI
Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.$1,165,858
UH3 · FY2018 · NS · contact PI
Core D: Neuropathology Core$379,128
P30 · FY2018 · AG · contact PI
Epidemiologic Study of TDP-43 Pathology in Aging and Dementia$242,673
R01 · FY2018 · AG · contact PI
Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.$1,102,656
UH2 · FY2017 · NS · contact PI
Core D: Neuropathology Core$383,859
P30 · FY2017 · AG · contact PI
Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease$2,827,258
RF1 · FY2016 · AG · contact PI
Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.$1,111,944
UH2 · FY2016 · NS · contact PI
Epidemiologic Study of TDP-43 Pathology in Aging and Dementia$451,538
R01 · FY2016 · AG · contact PI
Core D: Neuropathology Core$381,581
P30 · FY2016 · AG · contact PI
Epidemiologic Study of TDP-43 Pathology in Aging and Dementia$437,990
R01 · FY2015 · AG · contact PI
Epidemiologic Study of TDP-43 Pathology in Aging and Dementia$394,541
R01 · FY2014 · AG · contact PI
Epidemiologic Study of TDP-43 Pathology in Aging and Dementia$395,684
R01 · FY2013 · AG · contact PI
Epidemiologic Study of TDP-43 Pathology in Aging and Dementia$445,274
R01 · FY2012 · AG · contact PI
CORE--NEUROPATHOLOGY$437,343
P30 · FY2010 · AG · contact PI
CORE--NEUROPATHOLOGY$430,782
P30 · FY2009 · AG · contact PI
CORE--NEUROPATHOLOGY$431,933
P30 · FY2008 · AG · contact PI
CORE--NEUROPATHOLOGY$460,426
P30 · FY2007 · AG · contact PI
CORE--NEUROPATHOLOGY$249,831
P30 · FY2006 · AG · contact PI
EPIDEMIOLOGY, PATHOLOGY, AND PARKINSONISM IN AGING$121,505
K08 · FY2004 · AG
EPIDEMIOLOGY, PATHOLOGY, AND PARKINSONISM IN AGING$120,955
K08 · FY2003 · AG
EPIDEMIOLOGY, PATHOLOGY, AND PARKINSONISM IN AGING$120,420
K08 · FY2002 · AG
EPIDEMIOLOGY, PATHOLOGY, AND PARKINSONISM IN AGING$116,208
K08 · FY2001 · AG
EPIDEMIOLOGY, PATHOLOGY, AND PARKINSONISM IN AGING$99,360
K08 · FY2000 · AG